222 related articles for article (PubMed ID: 30816632)
1. Acquisition of Sexually Transmitted Infections among Women Using a Variety of Contraceptive Options: A prospective Study among High-risk African Women.
Kiweewa FM; Brown E; Mishra A; Nair G; Palanee-Phillips T; Mgodi N; Nakabiito C; Chakhtoura N; Hillier SL; Baeten JM;
J Int AIDS Soc; 2019 Feb; 22(2):e25257. PubMed ID: 30816632
[TBL] [Abstract][Full Text] [Related]
2. Prevalence and incidence of sexually transmitted infections among South African women initiating injectable and long-acting contraceptives.
Harryparsad R; Meyer B; Taku O; Serrano M; Chen PL; Gao X; Williamson AL; Mehou-Loko C; d'Hellencourt FL; Smit J; Strauss J; Nanda K; Ahmed K; Beksinska M; Buck G; Morrison C; Deese J; Masson L
PLoS One; 2023; 18(11):e0294285. PubMed ID: 37948399
[TBL] [Abstract][Full Text] [Related]
3. Risk of HIV-1 acquisition among South African women using a variety of contraceptive methods in a prospective study.
Palanee-Phillips T; Brown ER; Szydlo D; Matovu Kiweewa F; Pather A; Harkoo I; Nair G; Soto-Torres L; Hillier SL; Baeten JM;
AIDS; 2019 Aug; 33(10):1619-1622. PubMed ID: 31306167
[TBL] [Abstract][Full Text] [Related]
4. HIV incidence among women using intramuscular depot medroxyprogesterone acetate, a copper intrauterine device, or a levonorgestrel implant for contraception: a randomised, multicentre, open-label trial.
Evidence for Contraceptive Options and HIV Outcomes (ECHO) Trial Consortium
Lancet; 2019 Jul; 394(10195):303-313. PubMed ID: 31204114
[TBL] [Abstract][Full Text] [Related]
5. Population-Level Correlation Between Incidence of Curable Sexually Transmitted Infections and Human Immunodeficiency Virus (HIV)-1 Among African Women Participating in HIV-1 Pre-Exposure Prophylaxis Trials.
Hunidzarira P; Brown ER; Chirenje ZM; Hillier SL; Marrazzo JM; Palanee-Phillips T; Kiweewa FM; Baeten JM;
J Infect Dis; 2022 Sep; 226(6):1069-1074. PubMed ID: 35763413
[TBL] [Abstract][Full Text] [Related]
6. Risk Factors for Incidence of Sexually Transmitted Infections Among Women in a Human Immunodeficiency Virus Chemoprevention Trial: VOICE (MTN-003).
Chirenje ZM; Gundacker HM; Richardson B; Rabe L; Gaffoor Z; Nair GL; Mirembe BG; Piper JM; Hillier S; Marrazzo J
Sex Transm Dis; 2017 Mar; 44(3):135-140. PubMed ID: 28178109
[TBL] [Abstract][Full Text] [Related]
7. Highly effective contraception and acquisition of HIV and other sexually transmitted infections.
Morrison CS; Turner AN; Jones LB
Best Pract Res Clin Obstet Gynaecol; 2009 Apr; 23(2):263-84. PubMed ID: 19211309
[TBL] [Abstract][Full Text] [Related]
8. Contraceptive method switching among women living in sub-Saharan Africa participating in an HIV-1 prevention trial: a prospective cohort study.
Chappell CA; Harkoo I; Szydlo DW; Bunge KE; Singh D; Nakabiito C; Mhlanga F; Kamira B; Piper JM; Balkus JE; Hillier SL;
Contraception; 2019 Sep; 100(3):214-218. PubMed ID: 31226323
[TBL] [Abstract][Full Text] [Related]
9. African women recently infected with HIV-1 and HSV-2 have increased risk of acquiring Neisseria gonorrhoeae and Chlamydia trachomatis in the Methods for Improving Reproductive Health in Africa trial.
Venkatesh KK; van der Straten A; Mayer KH; Blanchard K; Ramjee G; Lurie MN; Chipato T; Padian NS; de Bruyn G
Sex Transm Dis; 2011 Jun; 38(6):562-70. PubMed ID: 21278624
[TBL] [Abstract][Full Text] [Related]
10. Associations between intravaginal practices and incidence of sexually transmitted infections and bacterial vaginosis among women enrolled in the dapivirine vaginal ring trial (The Ring Study) in southwestern Uganda: a retrospective secondary analysis.
Kusemererwa S; Ruzagira E; Onyango M; Kabarambi A; Abaasa A
BMJ Open; 2024 Apr; 14(4):e079497. PubMed ID: 38589266
[TBL] [Abstract][Full Text] [Related]
11. Sexually transmitted infections among women randomised to depot medroxyprogesterone acetate, a copper intrauterine device or a levonorgestrel implant.
Deese J; Philip N; Lind M; Ahmed K; Batting J; Beksinska M; Edward VA; Louw CE; Onono M; Palanee-Phillips T; Smit JA; Baeten JM; Donnell D; Mastro TD; Mugo NR; Nanda K; Rees H; Morrison C
Sex Transm Infect; 2021 Jun; 97(4):249-255. PubMed ID: 33208512
[TBL] [Abstract][Full Text] [Related]
12. High prevalence and incidence of gonorrhoea and chlamydia in young women eligible for HIV pre-exposure prophylaxis in South Africa and Zimbabwe: results from the HPTN 082 trial.
Delany-Moretlwe S; Mgodi N; Bekker LG; Baeten JM; Li C; Donnell D; Agyei Y; Lennon D; Rose SM; Mokgatle M; Kassim S; Mukaka S; Adeyeye A; Celum C
Sex Transm Infect; 2023 Nov; 99(7):433-439. PubMed ID: 36889914
[TBL] [Abstract][Full Text] [Related]
13. Prevalence and Incidence of Sexually Transmitted Infection in Injectable Progestin Contraception Users in South Africa.
Noguchi LM; Marrazzo JM; Richardson B; Hillier SL; Balkus JE; Palanee-Phillips T; Nair G; Panchia R; Piper J; Gomez K; Ramjee G; Chirenje ZM
Front Reprod Health; 2021 Jul; 3():. PubMed ID: 35669097
[TBL] [Abstract][Full Text] [Related]
14. Prospective study of hormonal contraception and women's risk of HIV infection in South Africa.
Myer L; Denny L; Wright TC; Kuhn L
Int J Epidemiol; 2007 Feb; 36(1):166-74. PubMed ID: 17175547
[TBL] [Abstract][Full Text] [Related]
15. Brief Report: Dapivirine Vaginal Ring Use Does Not Diminish the Effectiveness of Hormonal Contraception.
Balkus JE; Palanee-Phillips T; Reddy K; Siva S; Harkoo I; Nakabiito C; Kintu K; Nair G; Chappell C; Kiweewa FM; Kabwigu S; Naidoo L; Jeenarain N; Marzinke M; Soto-Torres L; Brown ER; Baeten JM
J Acquir Immune Defic Syndr; 2017 Oct; 76(2):e47-e51. PubMed ID: 28542081
[TBL] [Abstract][Full Text] [Related]
16. Trends of HIV-1 and sexually transmitted diseases among pregnant and postpartum women in urban Malawi.
Taha TE; Dallabetta GA; Hoover DR; Chiphangwi JD; Mtimavalye LA; Liomba GN; Kumwenda NI; Miotti PG
AIDS; 1998 Jan; 12(2):197-203. PubMed ID: 9468369
[TBL] [Abstract][Full Text] [Related]
17. Hormonal contraception and risk of STIs and bacterial vaginosis in South African adolescents: secondary analysis of a randomised trial.
Balle C; Gill K; Konstantinus IN; Jaumdally SZ; Lennard K; Esra R; Happel AU; Barnabas SL; Gamieldien H; Pidwell T; Maseko V; Lesosky M; Myer L; Passmore JS; Bekker LG; Jaspan HB
Sex Transm Infect; 2021 Mar; 97(2):112-117. PubMed ID: 32989170
[TBL] [Abstract][Full Text] [Related]
18. Contraceptive method preference and reasons for contraceptive discontinuation among women randomized to intramuscular depot medroxyprogesterone acetate, a copper intrauterine device or a levonorgestrel implant: Findings from Durban, South Africa.
Beesham I; Bosman S; Beksinska M; Scoville CW; Smit J; Nanda K
Contraception; 2022 Apr; 108():37-43. PubMed ID: 34848180
[TBL] [Abstract][Full Text] [Related]
19. Risk of HIV-1 acquisition among women who use diff erent types of injectable progestin contraception in South Africa: a prospective cohort study.
Noguchi LM; Richardson BA; Baeten JM; Hillier SL; Balkus JE; Chirenje ZM; Bunge K; Ramjee G; Nair G; Palanee-Phillips T; Selepe P; van der Straten A; Parikh UM; Gomez K; Piper JM; Watts DH; Marrazzo JM;
Lancet HIV; 2015 Jul; 2(7):e279-87. PubMed ID: 26155597
[TBL] [Abstract][Full Text] [Related]
20. Use of injectable progestin contraception and risk of STI among South African women.
Pettifor A; Delany S; Kleinschmidt I; Miller WC; Atashili J; Rees H
Contraception; 2009 Dec; 80(6):555-60. PubMed ID: 19913149
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
